Nanomedicine in pulmonary delivery

References

• YangWPetersJIWilliamsRO3rdInhaled nanoparticles–a current reviewInt J Pharm200835623924718358652
   PubMed Web of Science ®Google Scholar
• PattonJSByronPRInhaling medicines: delivering drugs to the body through the lungsNat Rev Drug Discov20076677417195033
   PubMed Web of Science ®Google Scholar
• SungJCPulliamBLEdwardsDANanoparticles for drug delivery to the lungsTrends Biotechnol20072556357017997181
   PubMed Web of Science ®Google Scholar
• BaileyMMBerklandCJNanoparticle formulations in pulmonary drug deliveryMed Res Rev20092919621218958847
   PubMed Web of Science ®Google Scholar
• ShekunovBNanoparticle technology for drug delivery – From nanoparticles to cutting-edge delivery strategies – Part I – 21–22 March 2005, Philadelphia, PA, USAIdrugs2005839940115883921
   PubMed Web of Science ®Google Scholar
• KreuterJNanoparticle-based drug delivery systemsJ Control Release199116169176
   Web of Science ®Google Scholar
• BriggerIDubernetCCouvreurPNanoparticles in cancer therapy and diagnosisAdv Drug Deliv Rev20025463165112204596
   PubMed Web of Science ®Google Scholar
• TiwariSBAmijiMMA review of nanocarrier-based CNS delivery systemsCurr Drug Deliv2006321923216611008
   PubMedGoogle Scholar
• KaurIPBhandariRBhandariSKakkarVPotential of solid lipid nanoparticles in brain targetingJ Control Release20081279710918313785
   PubMed Web of Science ®Google Scholar
• DriscollDBhargavaHLiLZaimRBabayanVBistrianBPhysicochemical stability of total nutrient admixturesAm J Health Syst Pharm1995526236347606577
   PubMed Web of Science ®Google Scholar
• KosterVSKuksPFMLangeRTalsmaHParticle size in parenteral fat emulsions, what are the true limitations?Int J Pharm1996134235238
   Web of Science ®Google Scholar
• ZimmerAKreuterJMicrospheres and nanoparticles used in ocular delivery systemsAdv Drug Deliv Rev1995166173
   Web of Science ®Google Scholar
• ChonoSTaninoTSekiTMorimotoKInfluence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomesJ Drug Target20061455756617043040
   PubMed Web of Science ®Google Scholar
• ParkJHLeeSKimJHParkKKimKKwonICPolymeric nanomedicine for cancer therapyProg Polym Sci200833113137
   Web of Science ®Google Scholar
• ResnikDBTinkleSSEthical issues in clinical trials involving nanomedicineContemp Clin Trials20072843344117166777
   PubMed Web of Science ®Google Scholar
• AzarmiSRoaWHLobenbergRTargeted delivery of nanoparticles for the treatment of lung diseasesAdv Drug Deliv Rev20086086387518308418
   PubMed Web of Science ®Google Scholar
• CryanSACarrier-based strategies for targeting protein and peptide drugs to the lungsAAPS J20057E20E4116146340
   PubMed Web of Science ®Google Scholar
• JoshiMRMisraALiposomal budesonide for dry powder inhaler: preparation and stabilizationAAPS Pharm Sci Tech2001225
   PubMedGoogle Scholar
• KonduriKSNandedkarSDuzgunesNEfficacy of liposomal budesonide in experimental asthmaJ Allergy Clin Immunol200311132132712589352
   PubMed Web of Science ®Google Scholar
• StentonGRUlanovaMDeryREInhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinaseJ Immunol20021691028103612097411
   PubMed Web of Science ®Google Scholar
• JoshiMMisraADisposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lungClin Exp Pharmacol Physiol20033015315612603343
   PubMed Web of Science ®Google Scholar
• SeongJHLeeKMKimSTJinSEKimCKPolyethylenimine-based antisense oligodeoxynucleotides of IL-4 suppress the production of IL-4 in a murine model of airway inflammationJ Gene Med2006831432316292779
   PubMed Web of Science ®Google Scholar
• ChattopadhyayPShekunovBYYimDCipollaDBoydBFarrSProduction of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx systemAdv Drug Deliv Rev20075944445317582648
   PubMed Web of Science ®Google Scholar
• HajosFStarkBHenslerSPrasslRMosgoellerWInhalable liposomal formulation for vasoactive intestinal peptideInt J Pharm200835728629418328650
   PubMed Web of Science ®Google Scholar
• StarkBDebbagePAndreaeFMosgoellerWPrasslRAssociation of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary deliveryBiochim Biophys Acta2007176870571417204237
   PubMed Web of Science ®Google Scholar
• WernigKGriesbacherMAndreaeFDepot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticlesJ Control Release200813019219818601963
   PubMed Web of Science ®Google Scholar
• WijagkanalanWKawakamiSTakenagaMIgarashiRYamashitaFHashidaMEfficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in ratsJ Control Release200812512113018037185
   PubMed Web of Science ®Google Scholar
• GongFTangHLinYGuWWangWKangMGene transfer of vascular endothelial growth factor reduces bleomycin-induced pulmonary hypertension in immature rabbitsPediatr Int20054724224715910444
   PubMed Web of Science ®Google Scholar
• KimuraSEgashiraKChenLNanoparticle-mediated delivery of nuclear factor {kappa}B decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertensionHypertension2009
   Web of Science ®Google Scholar
• ChouguleMBPadhiBKMisraANano-liposomal dry powder inhaler of Amiloride HydrochlorideJ Nanosci Nanotechnol200663001300917048511
   PubMed Web of Science ®Google Scholar
• GibbonsAMMcElvaneyNGTaggartCCCryanSADelivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradationJ Microencapsul2008110
   Web of Science ®Google Scholar
• BeaulacCSachetelliSLagaceJAerosolization of low phase transition temperature liposomal tobramycin as a dry powder in an animal model of chronic pulmonary infection caused by Pseudomonas aeruginosaJ Drug Target19997334110614813
   PubMed Web of Science ®Google Scholar
• MarierJFBrazierJLLavigneJDucharmeMPLiposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in ratsJ Antimicrob Chemother20035224725212837733
   PubMed Web of Science ®Google Scholar
• LabanaSPandeyRSharmaSKhullerGKChemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomesInt J Antimicrob Agents20022030130412385689
   PubMed Web of Science ®Google Scholar
• VyasSPKannanMEJainSMishraVSinghPDesign of liposomal aerosols for improved delivery of rifampicin to alveolar macrophagesInt J Pharm2004269374914698575
   PubMed Web of Science ®Google Scholar
• ChangsanNChanHKSeparovicFSrichanaTPhysicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalationJ Pharm Sci20099862863918484099
   PubMed Web of Science ®Google Scholar
• JustoORMoraesAMIncorporation of antibiotics in liposomes designed for tuberculosis therapy by inhalationDrug Deliv20031020120712944141
   PubMed Web of Science ®Google Scholar
• PandeyRSharmaAZahoorASharmaSKhullerGKPrasadBPoly(DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosisJ Antimicrob Chemother20035298198614613962
   PubMed Web of Science ®Google Scholar
• ZahoorASharmaSKhullerGKInhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosisInt J Antimicrob Agents20052629830316154726
   PubMed Web of Science ®Google Scholar
• EsmaeiliFHosseini-NasrMRad-MalekshahiMSamadiNAtyabiFDinarvandRPreparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticlesNanomedicine2007316116717468055
   PubMed Web of Science ®Google Scholar
• OhashiKKabasawaTOzekiTOkadaHOne-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosisJ Control Release2009135192419121349
   PubMed Web of Science ®Google Scholar
• PandeyRKhullerGKSolid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosisTuberculosis (Edinb)20058522723415922668
   PubMed Web of Science ®Google Scholar
• WongJPYangHBlasettiKLSchnellGConleyJSchofieldLNLiposome delivery of ciprofloxacin against intracellular Francisella tularensis infectionJ Control Release20039226527314568408
   PubMed Web of Science ®Google Scholar
• SweeneyLGWangZLoebenbergRWongJPLangeCFFinlayWHSpray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug deliveryInt J Pharm200530518018516242277
   PubMed Web of Science ®Google Scholar
• ShahSPMisraADevelopment of liposomal amphotericin B dry powder inhaler formulationDrug Deliv20041124725315371106
   PubMed Web of Science ®Google Scholar
• VyasSPQuraishiSGuptaSJaganathanKSAerosolized liposome-based delivery of amphotericin B to alveolar macrophagesInt J Pharm2005296122515885451
   PubMed Web of Science ®Google Scholar
• KhannaCAndersonPMHaszDEKatsanisENevilleMKlausnerJSInterleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastasesCancer199779140914219083164
   PubMed Web of Science ®Google Scholar
• DensmoreCLKleinermanESGautamAGrowth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexesCancer Gene Ther2001861962711593330
   PubMed Web of Science ®Google Scholar
• GautamADensmoreCLWaldrepJCInhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexesMol Ther2000231832311020346
   PubMed Web of Science ®Google Scholar
• KoshkinaNVAgoulnikIYMeltonSLDensmoreCLKnightVBiodistribution and pharmacokinetics of aerosol and intravenously administered DNA-polyethyleneimine complexes: optimization of pulmonary delivery and retentionMol Ther2003824925412907147
   PubMed Web of Science ®Google Scholar
• GautamADensmoreCLMeltonSGolunskiEWaldrepJCAerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesisCancer Gene Ther20029283611916242
   PubMed Web of Science ®Google Scholar
• VerschraegenCFGilbertBELoyerEClinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignanciesClin Cancer Res2004102319232615073107
   PubMed Web of Science ®Google Scholar
• ShahiwalaAMisraAA preliminary pharmacokinetic study of liposomal leuprolide dry powder inhaler: a technical noteAAPS Pharm Sci Tech20056E482E486
   PubMed Web of Science ®Google Scholar
• AzarmiSTaoXChenHFormulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particlesInt J Pharm200631915516116713150
   PubMed Web of Science ®Google Scholar
• HwangSKJinHKwonJTAerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter miceGene Ther2007141353136117611588
   PubMed Web of Science ®Google Scholar
• JinHKimTHHwangSKAerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null miceMol Cancer Ther200651041104916648576
   PubMed Web of Science ®Google Scholar
• TaetzSNafeeNBeisnerJThe influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2’-O-methyl-RNA directed against telomerase in lung cancer cellsEur J Pharm Biopharm20097235836918703137
   PubMed Web of Science ®Google Scholar
• JereDXuCXAroteRYunCHChoMHChoCSPoly(betaamino ester) as a carrier for si/shRNA delivery in lung cancer cellsBiomaterials2008292535254718316120
   PubMed Web of Science ®Google Scholar
• XuCXJereDJinHPoly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesisAm J Respir Crit Care Med2008178607318310482
   PubMed Web of Science ®Google Scholar
• TomodaKOhkoshiTHirotaKPreparation and properties of inhalable nanocomposite particles for treatment of lung cancerColloids Surf B Biointerfaces20097117718219264458
   PubMed Web of Science ®Google Scholar
• de SemirDPetrizJAvinyoANon-viral vector-mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cellsJ Gene Med2002430832212112648
   PubMed Web of Science ®Google Scholar
• GilbertBEKnightCAlvarezFGTolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosolAm J Respir Crit Care Med1997156178917939412556
   PubMed Web of Science ®Google Scholar
• ChouguleMPadhiBMisraANano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokineticsInt J Nanomedicine2007267568818203434
   PubMed Web of Science ®Google Scholar
• Bivas-BenitaMvan MeijgaardenKEFrankenKLPulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosisVaccine2004221609161515068842
   PubMed Web of Science ®Google Scholar
• Bivas-BenitaMOudshoornMRomeijnSCationic submicron emulsions for pulmonary DNA immunizationJ Control Release200410014515515491818
   PubMed Web of Science ®Google Scholar
• KaipelMWagnerAWassermannEIncreased biological half-life of aerosolized liposomal recombinant human Cu/Zn superoxide dismutase in pigsJ Aerosol Med Pulm Drug Deliv20082128129018578594
   PubMed Web of Science ®Google Scholar
• CarpenterMEpperlyMWAgarwalAInhalation delivery of manganese superoxide dismutase-plasmid/liposomes protects the murine lung from irradiation damageGene Ther20051268569315750616
   PubMed Web of Science ®Google Scholar
• EpperlyMWGuoHLJeffersonMCell phenotype specific kinetics of expression of intratracheally injected manganese superoxide dismutase-plasmid/liposomes (MnSOD-PL) during lung radioprotective gene therapyGene Ther20031016317112571645
   PubMed Web of Science ®Google Scholar
• YamamotoHKunoYSugimotoSTakeuchiHKawashimaYSurfacemodified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctionsJ Control Release200510237338115653158
   PubMed Web of Science ®Google Scholar
• ZhangQShenZNagaiTProlonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal ratsInt J Pharm2001218758011337151
   PubMed Web of Science ®Google Scholar
• HuangYYWangCHPulmonary delivery of insulin by liposomal carriersJ Control Release200611391416730838
   PubMed Web of Science ®Google Scholar
• BiRShaoWWangQZhangNSpray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary deliveryJ Drug Target20081663964818982512
   PubMed Web of Science ®Google Scholar
• LiuJGongTFuHSolid lipid nanoparticles for pulmonary delivery of insulinInt J Pharm200835633334418281169
   PubMed Web of Science ®Google Scholar
• BaiSThomasCAhsanFDendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparinJ Pharm Sci2007962090210617286291
   PubMed Web of Science ®Google Scholar
• BaiSAhsanFSynthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparinPharm Res20092653954819034631
   PubMed Web of Science ®Google Scholar
• PirasAMChielliniFFiumiCA new biocompatible nanoparticle delivery system for the release of fibrinolytic drugsInt J Pharm200835726027118313868
   PubMed Web of Science ®Google Scholar
• PlumleyCGormanEMEl-GendyNBybeeCRMunsonEJBerklandCNifedipine nanoparticle agglomeration as a dry powder aerosol formulation strategyInt J Pharm200936913614319015016
   PubMed Web of Science ®Google Scholar
• AlmeidaAJSoutoESolid lipid nanoparticles as a drug delivery system for peptides and proteinsAdv Drug Deliv Rev20075947849017543416
   PubMed Web of Science ®Google Scholar
• Koping-HoggardMVarumKMIssaMImproved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomersGene Ther2004111441145215269712
   PubMed Web of Science ®Google Scholar
• HowardKARahbekULLiuXRNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle systemMol Ther20061447648416829204
   PubMed Web of Science ®Google Scholar
• GrenhaASeijoBRemunan-LopezCMicroencapsulated chitosan nanoparticles for lung protein deliveryEur J Pharm Sci20052542743715893461
   PubMed Web of Science ®Google Scholar
• IssaMMKoping-HoggardMTommeraasKTargeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivoJ Control Release200611510311216901570
   PubMed Web of Science ®Google Scholar
• BrzoskaMLangerKCoesterCLoitschSWagnerTOMallinckrodtCIncorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseasesBiochem Biophys Res Commun200431856257015120637
   PubMed Web of Science ®Google Scholar
• ShamJOZhangYFinlayWHRoaWHLobenbergRFormulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lungInt J Pharm200426945746714706257
   PubMed Web of Science ®Google Scholar
• KaulGAmijiMTumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studiesPharm Res20052295196115948039
   PubMed Web of Science ®Google Scholar
• ElyLRoaWFinlayWHLobenbergREffervescent dry powder for respiratory drug deliveryEur J Pharm Biopharm20076534635317156987
   PubMed Web of Science ®Google Scholar
• Beck-BroichsitterMGaussJPackhaeuserCBPulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung modelInt J Pharm200936716917818848609
   PubMed Web of Science ®Google Scholar
• LynchJBehanNBirkinshawCFactors controlling particle size during nebulization of DNA-polycation complexesJ Aerosol Med20072025726817894533
   PubMedGoogle Scholar
• ChenJGaoXHuKGalactose-poly(ethylene glycol)-poly-ethylenimine for improved lung gene transferBiochem Biophys Res Commun200837537838318694731
   PubMed Web of Science ®Google Scholar
• NguyenJXieXNeuMEffects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungsJ Gene Med2008101236124618780309
   PubMed Web of Science ®Google Scholar
• ZiadyAGGedeonCRMuhammadOMinimal toxicity of stabilized compacted DNA nanoparticles in the murine lungMol Ther2003894895614664797
   PubMed Web of Science ®Google Scholar
• ZiadyAGGedeonCRMillerTTransfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivoMol Ther2003893694714664796
   PubMed Web of Science ®Google Scholar
• Kukowska-LatalloJFRaczkaEQuintanaAChenCRymaszewskiMBakerJRJrIntravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vectorHum Gene Ther2000111385139510910136
   PubMed Web of Science ®Google Scholar
• de FougerollesARDelivery vehicles for small interfering RNA in vivoHum Gene Ther20081912513218257677
   PubMed Web of Science ®Google Scholar
• DensmoreCLAdvances in noninvasive pulmonary gene therapyCurr Drug Deliv20063556316472094
   PubMedGoogle Scholar
• De SmedtSCDemeesterJHenninkWECationic polymer based gene delivery systemsPharm Res20001711312610751024
   PubMed Web of Science ®Google Scholar
• WightmanLKircheisRRosslerVDifferent behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivoJ Gene Med2001336237211529666
   PubMed Web of Science ®Google Scholar
• KichlerALeborgneCCoeytauxEDanosOPolyethylenimine-mediated gene delivery: a mechanistic studyJ Gene Med2001313514411318112
   PubMed Web of Science ®Google Scholar
• CholletPFavrotMCHurbinACollJLSide-effects of a systemic injection of linear polyethylenimine-DNA complexesJ Gene Med20024849111828391
   PubMed Web of Science ®Google Scholar
• TangMXSzokaFCThe influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexesGene Ther199748238329338011
   PubMed Web of Science ®Google Scholar
• OgrisMWagnerETumor-targeted gene transfer with DNA polyplexesSomat Cell Mol Genet200227859512774943
   PubMedGoogle Scholar
• RudolphCSchillingerUPlankCNonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimineBiochim Biophys Acta20021573758312383945
   PubMed Web of Science ®Google Scholar
• LiSDHuangLSurface-modified LPD nanoparticles for tumor targetingAnn N Y Acad Sci200610821817145918
   PubMed Web of Science ®Google Scholar
• EliyahuHJosephASchillemansJPAzzamTDombAJBarenholzYCharacterization and in vivo performance of dextranspermine polyplexes and DOTAP/cholesterol lipoplexes administered locally and systemicallyBiomaterials2007282339234917298842
   PubMed Web of Science ®Google Scholar
• ChonoSLiSDConwellCCHuangLAn efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumorJ Control Release2008131646918674578
   PubMed Web of Science ®Google Scholar
• ParkMRKimHWHwangCSHighly efficient gene transfer with degradable poly(ester amine) based on poly(ethylene glycol) diacrylate and polyethylenimine in vitro and in vivoJ Gene Med20081019820718064729
   PubMed Web of Science ®Google Scholar
• KoYTKaleAHartnerWCPapahadjopoulos-SternbergBTorchilinVPSelf-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene deliveryJ Control Release200913313213818929605
   PubMed Web of Science ®Google Scholar
• ZengXMMartinGPMarriottCThe controlled delivery of drugs to the lungInt J Pharm1995124149164
   Web of Science ®Google Scholar
• MullerRHMaderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm20005016117710840199
   PubMed Web of Science ®Google Scholar
• SchreierHGonzalez-RothiRJStecenkoAAPulmonary delivery of liposomesJ Control Release199324209223
   Web of Science ®Google Scholar
• TaylorKMGTaylorGKellawayIWStevensJThe stability of liposomes to nebulisationInt J Pharm1990585761
   Web of Science ®Google Scholar
• JoshiMMisraANPulmonary disposition of budesonide from liposomal dry powder inhalerMethods Find Exp Clin Pharmacol20012353153611957743
   PubMed Web of Science ®Google Scholar
• ShahSPMisraALiposomal amphotericin B dry powder inhaler: effect of fines on in vitro performancePharmazie20045981281315544064
   PubMed Web of Science ®Google Scholar
• WhiteSBennettDBCheuSEXUBERA: pharmaceutical development of a novel product for pulmonary delivery of insulinDiabetes Technol Ther2005789690616386095
   PubMedGoogle Scholar
• StriblingRBrunetteELiggittDGaenslerKDebsRAerosol gene delivery in vivoProc Natl Acad Sci U S A19928911277112811454808
   PubMed Web of Science ®Google Scholar
• AltonEWMiddletonPGCaplenNJNon-invasive liposomemediated gene delivery can correct the ion transport defect in cystic fibrosis mutant miceNat Genet199351351427504552
   PubMed Web of Science ®Google Scholar
• ChadwickSLKingstonHDSternMSafety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteersGene Ther199749379429349430
   PubMed Web of Science ®Google Scholar
• OudrhiriNVigneronJPPeuchmaurMLeclercTLehnJMLehnPGene transfer by guanidinium-cholesterol cationic lipids into airway epithelial cells in vitro and in vivoProc Natl Acad Sci U S A199794165116569050833
   PubMed Web of Science ®Google Scholar
• PillaiRPetrakKBlezingerPUltrasonic nebulization of cationic lipid-based gene delivery systems for airway administrationPharm Res199815174317479833997
   PubMed Web of Science ®Google Scholar
• DensmoreCLGiddingsTHWaldrepJCKinseyBMKnightVGene transfer by guanidinium-cholesterol: dioleoylphosphatidyl-ethanolamine liposome-DNA complexes in aerosolJ Gene Med1999125126410738558
   PubMed Web of Science ®Google Scholar
• GautamADensmoreCLWaldrepJCPulmonary cytokine responses associated with PEI-DNA aerosol gene therapyGene Ther2001825425711313798
   PubMed Web of Science ®Google Scholar
• PitardBOudrhiriNLambertOSterically stabilized BGTC-based lipoplexes: structural features and gene transfection into the mouse airways in vivoJ Gene Med2001347848711601761
   PubMed Web of Science ®Google Scholar
• DeshpandeDSBlanchardJDSchusterJGamma scintigraphic evaluation of a miniaturized AERx pulmonary delivery system for aerosol delivery to anesthetized animals using a positive pressure ventilation systemJ Aerosol Med200518344415741772
   PubMedGoogle Scholar
• TempletonNSNonviral delivery for genomic therapy of cancerWorld J Surg20093368569719023615
   PubMed Web of Science ®Google Scholar
• MorilleMPassiraniCVonarbourgAClavreulABenoitJPProgress in developing cationic vectors for non-viral systemic gene therapy against cancerBiomaterials2008293477349618499247
   PubMed Web of Science ®Google Scholar
• CryanSADevocelleMMoranPJHickeyAJKellyJGIncreased intracellular targeting to airway cells using octaarginine-coated liposomes: In vitro assessment of their suitability for inhalationMol Pharm2006310411216579639
   PubMed Web of Science ®Google Scholar
• MehnertWMaderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev20014716519611311991
   PubMed Web of Science ®Google Scholar
• SchwarzCMehnertWLucksJSM?lerRHSolid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilizationJ Control Release1994308396
   Web of Science ®Google Scholar
• WestesenKNovel lipid-based colloidal dispersions as potential drug administration systems – expectations and realityColloid Polym Sci2000278608618
   Web of Science ®Google Scholar
• MullerRHRuhlDRungeSSchulze-ForsterKMehnertWCytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactantPharm Res1997144584629144731
   PubMed Web of Science ®Google Scholar
• HeydenreichAVWestmeierRPedersenNPoulsenHSKristensenHGPreparation and purification of cationic solid lipid nanospheres–effects on particle size, physical stability and cell toxicityInt J Pharm2003254838712615415
   PubMed Web of Science ®Google Scholar
• RudolphCSchillingerUOrtizAApplication of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivoPharm Res2004211662166915497694
   PubMed Web of Science ®Google Scholar
• VideiraMAGanoLSantosCNevesMAlmeidaAJLymphatic uptake of lipid nanoparticles following endotracheal administrationJ Microencapsul20062385586217390627
   PubMed Web of Science ®Google Scholar
• VideiraMABotelhoMFSantosACGouveiaLFde LimaJJAlmeidaAJLymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticlesJ Drug Target20021060761312683665
   PubMed Web of Science ®Google Scholar
• LiuFYangJHuangLLiuDEffect of non-ionic surfactants on the formation of DNA/emulsion complexes and emulsion-mediated gene transferPharm Res199613164216468956328
   PubMed Web of Science ®Google Scholar
• YiSWYuneTYKimTWA cationic lipid emulsion/DNA complex as a physically stable and serum-resistant gene delivery systemPharm Res20001731432010801220
   PubMed Web of Science ®Google Scholar
• KimTWChungHKwonICSungHCJeongSYIn vivo gene transfer to the mouse nasal cavity mucosa using a stable cationic lipid emulsionMol Cells20001014214710850654
   PubMed Web of Science ®Google Scholar
• BoasUHeegaardPMDendrimers in drug researchChem Soc Rev200433436314737508
   PubMed Web of Science ®Google Scholar
• RudolphCLausierJNaundorfSMullerRHRoseneckerJIn vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimersJ Gene Med2000226927810953918
   PubMed Web of Science ®Google Scholar
• HickeyAJLung deposition and clearance of pharmaceutical aerosols: what can be learned from inhalation toxicology and industrial hygieneAerosol Sci Technol199318290304
   Web of Science ®Google Scholar
• HickeyAJMansourHMDelivery of drugs by the pulmonary routeFlorenceATSiepmannJModern PharmaceuticsNew York, NYTaylor and Francis, Inc2008191219
   Google Scholar
• Merisko-LiversidgeEMcGurkSLLiversidgeGGInsulin nanoparticles: a novel formulation approach for poorly water soluble ZninsulinPharm Res2004211545155315497677
   PubMed Web of Science ®Google Scholar
• RabinowBENanosuspensions in drug deliveryNat Rev Drug Discov2004378579615340388
   PubMed Web of Science ®Google Scholar
• MosénKBáckstromKThalbergKParticle formation and capture during spray drying of inhalable particlesPharm Dev Technol2004940941815581077
   PubMed Web of Science ®Google Scholar
• DudduSPSiskSAWalterYHImproved lung delivery from a passive dry powder inhaler using an Engineered PulmoSphere powderPharm Res20021968969512069174
   PubMed Web of Science ®Google Scholar
• MaaYFNguyenPASitKHsuCCSpray-drying performance of a bench-top spray dryer for protein aerosol powder preparationBiotechnol Bioeng19986030130910099432
   PubMed Web of Science ®Google Scholar
• FreitasSMerkleHPGanderBUltrasonic atomisation into reduced pressure atmosphere – envisaging aseptic spray-drying for microencapsulationJ Control Release20049518519514980767
   PubMed Web of Science ®Google Scholar
• StahlKClaessonMLilliehornPLindenHBackstromKThe effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalationInt J Pharm200223322723711897427
   PubMed Web of Science ®Google Scholar
• GilaniKNajafabadiARBarghiMRafiee-TehraniMThe effect of water to ethanol feed ratio on physical properties and aerosolization behavior of spray dried cromolyn sodium particlesJ Pharm Sci2005941048105915793812
   PubMed Web of Science ®Google Scholar
• VidgrenMTVidgrenPAParonenTPComparison of physical and inhalation properties of spray-dried and mechanically micronized disodium cromoglycateInt J Pharm198735139144
   Web of Science ®Google Scholar
• US Food and Drug AdministrationGuidance for industry: metered dose inhaler (MDI) and dry powder inhaler (DPI) drug products –chemistry, manufacturing, and controls documentationRockville, INUS Department of Health and Human Services1998
   Google Scholar
• KawashimaYSeriganoTHinoTYamamotoHTakeuchiHEffect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrateInt J Pharm1998172179188
   Web of Science ®Google Scholar
• VanderbistFWeryBPavonIMMoesAJOptimization of a dry powder inhaler formulation of nacystelyn, a new mucoactive agentJ Pharm Pharmacol1999511229123410632079
   PubMed Web of Science ®Google Scholar
• SteckelHBolzenNAlternative sugars as potential carriers for dry powder inhalationsInt J Pharm200427029730614726144
   PubMed Web of Science ®Google Scholar
• HarjunenPLankinenTSalonenHLehtoVPJarvinenKEffects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPIInt J Pharm200326315116312954190
   PubMed Web of Science ®Google Scholar
• RogersTJohnstonKWilliamsRSolution-based particle formation of pharmaceutical powders by supercritical or compressed Fluid CO2 and cryogenic spray-freezing technologiesDrug Dev Ind Pharm2001271003101611794803
   PubMed Web of Science ®Google Scholar
• MaaYFPrestrelskiSJBiopharmaceutical powders: particle formation and formulation considerationsCurr Pharm Biotechnol2000128330211469385
   PubMedGoogle Scholar
• MaaYFNguyenPASweeneyTShireSJHsuCCProtein inhalation powders: spray drying vs spray freeze dryingPharm Res19991624925410100310
   PubMed Web of Science ®Google Scholar
• YuZGarciaASJohnstonKPWilliamsRO3rdSpray freezing into liquid nitrogen for highly stable protein nanostructured microparticlesEur J Pharm Biopharm20045852953715451527
   PubMed Web of Science ®Google Scholar
• KuoJHHwangRPreparation of DNA dry powder for non-viral gene delivery by spray-freeze drying: effect of protective agents (polyethyleneimine and sugars) on the stability of DNAJ Pharm Pharmacol200456273314979998
   PubMed Web of Science ®Google Scholar
• TomJWDebenedettiPGParticle formation with supercritical fluids-a reviewJ Aerosol Sci199122555584
   Web of Science ®Google Scholar
• RehmanMShekunovBYYorkPOptimisation of powders for pulmonary delivery using supercritical fluid technologyEur J Pharm Sci20042211715113578
   PubMed Web of Science ®Google Scholar
• SteckelHThiesJMullerBWMicronizing of steroids for pulmonary delivery by supercritical carbon dioxideInt J Pharm199715299110
   Web of Science ®Google Scholar
• SteckelHMullerBWMetered-dose inhaler formulation of fluticasone-17-propionate micronized with supercritical carbon dioxide using the alternative propellant HFA-227Int J Pharm19981732533
   Web of Science ®Google Scholar
• ShekunovBYChattopadhyayPSeitzingerJHuffRNanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsionsPharm Res20062319620416307386
   PubMed Web of Science ®Google Scholar
• ChattopadhyayPHuffRShekunovBYDrug encapsulation using supercritical fluid extraction of emulsionsJ Pharm Sci20069566767916447174
   PubMed Web of Science ®Google Scholar
• El-BaseirMMPhippsMAKellawayIWPreparation and subsequent degradation of poly(l-lactic acid) microspheres suitable for aerosolisation: a physico-chemical studyInt J Pharm1997151145153
   Web of Science ®Google Scholar
• RasenackNSteckelHMullerBWMicronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization processJ Pharm Sci200392354412486680
   PubMed Web of Science ®Google Scholar
• ChowAHLTongHHYChattopadhyayPShekunovBYParticle engineering for pulmonary drug deliveryPharm Res20072441143717245651
   PubMed Web of Science ®Google Scholar
• GrattonSEAPohlhausPDLeeJGuoJChoMJDeSimoneJMNanofabricated particles for engineered drug therapies: A preliminary biodistribution study of PRINT™ nanoparticlesJ Control Release2007121101817643544
   PubMed Web of Science ®Google Scholar
• GrattonSERoppPAPohlhausPDThe effect of particle design on cellular internalization pathwaysProc Natl Acad Sci U S A2008105116131161818697944
   PubMed Web of Science ®Google Scholar
• GrattonSENapierMERoppPATianSDeSimoneJMMicrofabricated particles for engineered drug therapies: elucidation into the mechanisms of cellular internalization of PRINT particlesPharm Res2008252845285218592353
   PubMed Web of Science ®Google Scholar
• LiXBlondinoFEHindleMSoineWHByronPRStability and characterization of perphenazine aerosols generated using the capillary aerosol generatorInt J Pharm200530311312416139453
   PubMed Web of Science ®Google Scholar
• AvramMJHenthornTKSpykerDARecirculatory pharmacokinetic model of the uptake, distribution, and bioavailability of prochlorperazine administered as a thermally generated aerosol in a single breath to dogsDrug Metab Dispos20073526226717079359
   PubMed Web of Science ®Google Scholar
• RabinowitzJDWensleyMLloydPFast onset medications through thermally generated aerosolsJ Pharmacol Exp Ther200430976977514752061
   PubMed Web of Science ®Google Scholar
• HongJNHindleMByronPRControl of particle size by coagulation of novel condensation aerosols in reservoir chambersJ Aerosol Med20021535936812581502
   PubMedGoogle Scholar
• GuptaRHindleMByronPRCoxKAMcRaeDDInvestigation of a novel condensation aerosol generator: solute and solvent effectsAerosol Sci Technol200337672681
   Web of Science ®Google Scholar
• RabinowitzJDLloydPMMunzarPUltra-fast absorption of amorphous pure drug aerosols via deep lung inhalationJ Pharm Sci2006952438245116886198
   PubMed Web of Science ®Google Scholar
• MyersDJTimmonsRDLuATThe effect of film thickness on thermal aerosol generationPharm Res20072433634217180726
   PubMed Web of Science ®Google Scholar
• HickeyAJMansourHMTelkoMJPhysical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristicsJ Pharm Sci2007961282130117455324
   PubMed Web of Science ®Google Scholar
• WilliamsRO3rdBrownJLiuJInfluence of micronization method on the performance of a suspension triamcinolone acetonide pressurized metered-dose inhaler formulationPharm Dev Technol1999416717910231878
   PubMed Web of Science ®Google Scholar
• BarryPWO’CallaghanCAn in vitro analysis of the output of budesonide from different nebulizersJ Allergy Clin Immunol19991041168117310588997
   PubMed Web of Science ®Google Scholar
• SchauerJJChristensenCGKittelsonDBJohnsonJPWattsWFImpact of ambient temperatures and driving conditions on the chemical composition of particulate matter emissions from nonsmoking gasoline-powered motor vehiclesAerosol Sci Technol200842210223
   Web of Science ®Google Scholar
• MiguelAEiguren-FernandezASioutasCFinePGellerMMayoPObservations of twelve USEPA priority polycyclic aromatic hydrocarbons in the aitken size range (10–32 nm Dp)Aerosol Sci Technol200539415418
   Web of Science ®Google Scholar
• ParkKCaoFKittelsonDBMcMurryPHRelationship between particle mass and mobility for diesel exhaust particlesEnviron Sci Technol20033757758312630475
   PubMed Web of Science ®Google Scholar
• SardarSBFinePMMayoPRSioutasCSize-fractionated measurements of ambient ultrafine particle chemical composition in Los Angeles using the NanoMOUDIEnviron Sci Technol20053993294415773464
   PubMed Web of Science ®Google Scholar
• LinCCChenSJHuangKLCharacteristics of metals in nano/ultrafine/fine/coarse particles collected beside a heavily trafficked roadEnviron Sci Technol2005398113812216294844
   PubMed Web of Science ®Google Scholar
• GellerMDKimSMisraCSioutasCOlsonBAMarpleVAA methodology for measuring size-dependent chemical composition of ultrafine particlesAerosol Sci Technol200236748762
   Web of Science ®Google Scholar
• VenkatachariPHopkePKBruneWHCharacterization of wintertime reactive oxygen species concentrations in Flushing, New YorkAerosol Sci Technol20074197111
   Web of Science ®Google Scholar
• FujitaniYHasegawaSFushimiACollection characteristics of low-pressure impactors with various impaction substrate materialsAtmos Environ20064032213229
   Web of Science ®Google Scholar
• BatesSZografiGEngersDMorrisKCrowleyKNewmanAAnalysis of amorphous and nanocrystalline solids from their X-ray diffraction patternsPharm Res2006232333234917021963
   PubMed Web of Science ®Google Scholar
• LarhribHZengXMMartinGPMarriottCPritchardJThe use of different grades of lactose as a carrier for aerosolised salbutamol sulphateInt J Pharm199919111410556735
   PubMed Web of Science ®Google Scholar
• TrainiDYoungPMThielmannFAcharyaMThe influence of lactose pseudopolymorphic form on salbutamol sulfate-lactose interactions in DPI formulationsDrug Dev Ind Pharm200834992100118800259
   PubMed Web of Science ®Google Scholar
• NewmanAWByrnSRSolid-state analysis of the active pharmaceutical ingredient in drug productsDrug Discov Today2003889890514554018
   PubMed Web of Science ®Google Scholar
• Saleki-GerhardtAAhlneckCZografiGAssessment of disorder in crystalline solidsInt J Pharm1994101237247
   Web of Science ®Google Scholar
• BunkerMDaviesMRobertsCTowards screening of inhalation formulations: measuring interactions with atomic force microscopyExpert Opin Drug Deliv2005261362416296789
   PubMedGoogle Scholar
• SethuramanVVHickeyAJPowder properties and their influence on dry powder inhaler delivery of an antitubercular drugAAPS Pharm Sci Tech20023E28
   PubMedGoogle Scholar
• MansourHMZografiGThe relationship between water vapor absorption and desorption by phospholipids and bilayer phase transitionsJ Pharm Sci20079637739617080427
   PubMed Web of Science ®Google Scholar
• AguRUUgwokeMIArmandMKingetRVerbekeNThe lung as a route for systemic delivery of therapeutic proteins and peptidesRespir Res2001219820911686885
   PubMed Web of Science ®Google Scholar
• GronebergDAWittCWagnerUChungKFFischerAFundamentals of pulmonary drug deliveryRespir Med20039738238712693798
   PubMed Web of Science ®Google Scholar
• MathiasNRYamashitaFLeeVHLRespiratory epithelial cell culture models for evaluation of ion and drug transportAdv Drug Deliv Rev199622215249
   Web of Science ®Google Scholar
• ForbesBEhrhardtCHuman respiratory epithelial cell culture for drug delivery applicationsEur J Pharm Biopharm20056019320515939233
   PubMed Web of Science ®Google Scholar
• SakagamiMIn vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic deliveryAdv Drug Deliv Rev2006581030106017010473
   PubMed Web of Science ®Google Scholar
• MobleyCHochhausGMethods used to assess pulmonary deposition and absorption of drugsDrug Discov Today2001636737511267923
   PubMed Web of Science ®Google Scholar
• SteimerAHaltnerELehrCMCell culture models of the respiratory tract relevant to pulmonary drug deliveryJ Aerosol Med20051813718215966771
   PubMedGoogle Scholar
• BorchardGCassaráMLRoemeléPEHFloreaBIJungingerHETransport and local metabolism of budesonide and fluticasone propionate in a human bronchial epithelial cell line (Calu-3)J Pharm Sci2002911561156712115854
   PubMed Web of Science ®Google Scholar
• EhrhardtCFiegelJFuchsSDrug absorption by the respiratory mucosa: cell culture models and particulate drug carriersJ Aerosol Med20021513113912184863
   PubMedGoogle Scholar
• FosterKAAveryMLYazdanianMAudusKLCharacterization of the Calu-3 cell line as a tool to screen pulmonary drug deliveryInt J Pharm200020811111064206
   PubMed Web of Science ®Google Scholar
• FosterKAOsterCGMayerMMAveryMLAudusKLCharacterization of the A549 cell line as a type ii pulmonary epithelial cell model for drug metabolismExp Cell Res19982433593669743595
   PubMed Web of Science ®Google Scholar
• ManfordFTrondeAJeppssonABPatelNJohanssonFForbesBDrug permeability in 16HBE14o-airway cell layers correlates with absorption from the isolated perfused rat lungEur J Pharm Sci20052641442016153810
   PubMed Web of Science ®Google Scholar
• LinHLiHChoHJAir-liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studiesJ Pharm Sci20079634135017080426
   PubMed Web of Science ®Google Scholar
• VaughnJMMcConvilleJTBurgessDSingle dose and multiple dose studies of itraconazole nanoparticlesEur J Pharm Biopharm2006639510216516450
   PubMed Web of Science ®Google Scholar
• YangWTamJMillerDAHigh bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizersInt J Pharm200836117718818556158
   PubMed Web of Science ®Google Scholar
• McConvilleJTOverhoffKASinswatPTargeted high lung concentrations of itraconazole using nebulized dispersions in a murine modelPharm Res20062390191116715380
   PubMed Web of Science ®Google Scholar
• MizunoTMohriKNasuSDanjoKOkamotoHDual imaging of pulmonary delivery and gene expression of dry powder inhalant by fluorescence and bioluminescenceJ Control Release200913414915419100298
   PubMed Web of Science ®Google Scholar
• OberdorsterGSharpZAtudoreiVExtrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of ratsJ Toxicol Environ Health A2002651531154312396867
   PubMed Web of Science ®Google Scholar
• HeckelKKiefmannRDorgerMStoeckelhuberMGoetzAEColloidal gold particles as a new in vivo marker of early acute lung injuryAm J Physiol Lung Cell Mol Physiol2004287L867L87815194564
   PubMed Web of Science ®Google Scholar
• KatoTYashiroTMurataYEvidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillariesCell Tissue Res2003311475112483283
   PubMed Web of Science ®Google Scholar
• OberdorsterGSharpZAtudoreiVTranslocation of inhaled ultrafine particles to the brainInhal Toxicol20041643744515204759
   PubMed Web of Science ®Google Scholar
• OberdorsterGToxicology of ultrafine particles: in vivo studiesPhilos Trans R Soc Lond A200035827192740
   Web of Science ®Google Scholar
• BallouBLagerholmBCErnstLABruchezMPWaggonerASNoninvasive imaging of quantum dots in miceBioconjug Chem200415798614733586
   PubMed Web of Science ®Google Scholar
• OberdorsterGOberdorsterEOberdorsterJNanotoxicology: an emerging discipline evolving from studies of ultrafine particlesEnviron Health Perspect200511382383916002369
   PubMed Web of Science ®Google Scholar
• KreylingWGSemmlerMErbeFTranslocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very lowJ Toxicol Environ Health A2002651513153012396866
   PubMed Web of Science ®Google Scholar
• OberdorsterGFerinJMorrowPEVolumetric loading of alveolar macrophages (AM): a possible basis for diminished AM-mediated particle clearanceExp Lung Res199218871041572327
   PubMed Web of Science ®Google Scholar
• OberdorsterGFinkelsteinJNJohnstonCAcute pulmonary effects of ultrafine particles in rats and miceRes Rep Health Eff Inst2000574; disc 75–86.11205815
   PubMedGoogle Scholar
• FerinJOberdorsterGSoderholmSCGeleinRPulmonary tissue access of ultrafine particlesJ Aerosol Med199145768
   Google Scholar
• HickeyAJMansourHMFormulation challenges of powders for the delivery of small molecular weight molecules as aerosolsRathboneMJHadgraftJRobertsMSLaneMEModifiedrelease Drug Delivery TechnologyNew York, NYInforma Healthcare2008573601
   Google Scholar